Quantified prothrombotic factor group comparisons
. | PVI . | AIS . | Control . | P . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean . | SE . | 95% CI . | Mean . | SE . | 95% CI . | Mean . | SE . | 95% CI . | ||
PT, s | 11.8 | 0.12 | 10.3-13.3 | 11.3 | 0.09 | 10.1-12.6 | 11.9 | 0.10 | 10.6-13.5 | <.001* |
INR | 1.0 | 0.01 | 0.9-1.1 | 1.0 | 0.01 | 0.9-1.1 | 1.1 | 0.01 | 1.0-1.2 | <.001* |
PTT, s | 31.9 | 0.42 | 27.9-37.7 | 31.6 | 0.39 | 27.1-38.0 | 32.8 | 0.58 | 28.3-37.5 | .18 |
Fibrinogen, g/L | 2.5 | 0.07 | 1.8-3.3 | 2.5 | 0.07 | 1.7-3.8 | 2.4 | 0.06 | 1.7-3.3 | .51 |
Antithrombin, U/mL | 1.06 | 0.020 | 0.88-1.28 | 1.09 | 0.016 | 0.86-1.30 | 1.03 | 0.013 | 0.86-1.21 | .018* |
Protein C, U/mL | 0.87 | 0.027 | 0.63-1.24 | 0.87 | 0.025 | 0.51-1.22 | 0.87 | 0.025 | 0.52-1.27 | .99 |
Protein S activity, U/mL | 0.85 | 0.022 | 0.57-1.13 | 0.86 | 0.020 | 0.60-1.20 | 0.87 | 0.019 | 0.64-1.11 | .83 |
Protein S free, U/mL | 0.86 | 0.021 | 0.60-1.10 | 0.85 | 0.018 | 0.55-1.09 | 0.83 | 0.016 | 0.63-1.10 | .48 |
Factor VIII, U/mL | 1.04 | 0.046 | 0.58-1.69 | 1.00 | 0.032 | 0.64-1.47 | 1.00 | 0.034 | 0.60-1.53 | .72 |
Factor IX, U/mL | 0.77 | 0.018 | 0.60-1.01 | 0.80 | 0.023 | 0.54-1.17 | 0.76 | 0.018 | 0.54-1.07 | .32 |
Factor XI, U/mL | 1.00 | 0.037 | 0.62-1.39 | 1.02 | 0.033 | 0.69-1.58 | 1.15 | 0.032 | 0.77-1.57 | .004* |
Lp(a), g/L | 0.24 | 0.040 | 0.00-0.69 | 0.24 | 0.037 | 0.00-0.91 | 0.23 | 0.039 | 0.00-0.73 | .989 |
. | PVI . | AIS . | Control . | P . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean . | SE . | 95% CI . | Mean . | SE . | 95% CI . | Mean . | SE . | 95% CI . | ||
PT, s | 11.8 | 0.12 | 10.3-13.3 | 11.3 | 0.09 | 10.1-12.6 | 11.9 | 0.10 | 10.6-13.5 | <.001* |
INR | 1.0 | 0.01 | 0.9-1.1 | 1.0 | 0.01 | 0.9-1.1 | 1.1 | 0.01 | 1.0-1.2 | <.001* |
PTT, s | 31.9 | 0.42 | 27.9-37.7 | 31.6 | 0.39 | 27.1-38.0 | 32.8 | 0.58 | 28.3-37.5 | .18 |
Fibrinogen, g/L | 2.5 | 0.07 | 1.8-3.3 | 2.5 | 0.07 | 1.7-3.8 | 2.4 | 0.06 | 1.7-3.3 | .51 |
Antithrombin, U/mL | 1.06 | 0.020 | 0.88-1.28 | 1.09 | 0.016 | 0.86-1.30 | 1.03 | 0.013 | 0.86-1.21 | .018* |
Protein C, U/mL | 0.87 | 0.027 | 0.63-1.24 | 0.87 | 0.025 | 0.51-1.22 | 0.87 | 0.025 | 0.52-1.27 | .99 |
Protein S activity, U/mL | 0.85 | 0.022 | 0.57-1.13 | 0.86 | 0.020 | 0.60-1.20 | 0.87 | 0.019 | 0.64-1.11 | .83 |
Protein S free, U/mL | 0.86 | 0.021 | 0.60-1.10 | 0.85 | 0.018 | 0.55-1.09 | 0.83 | 0.016 | 0.63-1.10 | .48 |
Factor VIII, U/mL | 1.04 | 0.046 | 0.58-1.69 | 1.00 | 0.032 | 0.64-1.47 | 1.00 | 0.034 | 0.60-1.53 | .72 |
Factor IX, U/mL | 0.77 | 0.018 | 0.60-1.01 | 0.80 | 0.023 | 0.54-1.17 | 0.76 | 0.018 | 0.54-1.07 | .32 |
Factor XI, U/mL | 1.00 | 0.037 | 0.62-1.39 | 1.02 | 0.033 | 0.69-1.58 | 1.15 | 0.032 | 0.77-1.57 | .004* |
Lp(a), g/L | 0.24 | 0.040 | 0.00-0.69 | 0.24 | 0.037 | 0.00-0.91 | 0.23 | 0.039 | 0.00-0.73 | .989 |
Mean, standard error, and 95% CI for each continuous variable outcome are shown for PIV, AIS (comprising NAIS and APPIS), and controls. P value reflects significance of the original analysis of variance without correction for multiple comparisons.
INR, international normalized ratio; PT prothrombin time; PTT partial thromboplastin time.
Significant pairwise difference.